GPCRs: Researchers Disprove the Single Polypeptide Theory

For this article, Jim Kling interviewed Bryen A. Jordan, postdoctoral scientist in the lab of Edward Ziff at the New York University School of Medicine's department of biochemistry; Theresa Branchek, vice president of research at Synaptic Pharmaceutical Corp. (Paramus, NJ); and Christophe Gerald, vice president of target discovery and assessment at Synaptic Pharmaceutical. Data from the Web of Science (ISI, Philadelphia) show that Hot Papers are cited 50 to 100 times more often than the average

| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

This well-known family of seven-transmembrane-domain cell surface receptors respond to many signals, including photons, biogenic amines, lipids, peptides, and proteases. The receptors have many functions, most of them related to homeostatic control of processes such as blood pressure, respiration, and appetite.1 Studied for nearly 30 years, researchers thought they had a decent idea of what GPCRs looked like. "GPCRs have historically been thought to be single polypeptides," says Theresa Branchek, vice president of research at Synaptic Pharmaceutical Corp. Paramus, NJ.

The work at Synaptic Pharmaceuticals grew out of the company's focus on GPCRs in general. The GABA receptors include three types, A, B, and C, and the company focused on GABAB, in part because it is the only one of the three that is a GPCR, and also because Synaptic says it believes that the GABAB receptor will allow them to indirectly modulate pathways, perhaps producing a more subtle and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Jim Kling

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo